8 results
8-K
EX-10.1
ACXP
Acurx Pharmaceuticals, Inc.
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm
, surface water, groundwater, land surface or subsurface strata) and has all permits, authorizations and approvals required under any applicable
8-K
EX-10.1
4e260gt30m wfx0
25 Jul 22
Acurx Pharmaceuticals, Inc. Announces $4.225 Million Registered Direct Offering
8:46am
S-1/A
EX-1.1
gkkusy8oeg
11 Jun 21
IPO registration (amended)
6:02am
S-1
EX-1.1
c850p6l
27 May 21
IPO registration
12:00am
- Prev
- 1
- Next